Servier Pharmaceuticals shared a post on LinkedIn:
“Servier is thrilled to welcome Peter Adamson as Global Head of Oncology Clinical Development.
Peter is a globally recognized physician-scientist and executive leader who brings deep expertise across oncology drug development, clinical pharmacology and translational research. He’s held several leadership roles across academia, government and industry, where he’s led complex clinical programs and large research initiatives.
We look forward to growing under Peter’s leadership and continuing to advance our mission to deliver transformative therapies to patients with cancer.
Read the full announcement here.”
More posts featuring Peter Adamson.